Correlation Between Coya Therapeutics, and Denali Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Denali Therapeutics, you can compare the effects of market volatilities on Coya Therapeutics, and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Denali Therapeutics.

Diversification Opportunities for Coya Therapeutics, and Denali Therapeutics

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Coya and Denali is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Denali Therapeutics go up and down completely randomly.

Pair Corralation between Coya Therapeutics, and Denali Therapeutics

Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 1.68 times more return on investment than Denali Therapeutics. However, Coya Therapeutics, is 1.68 times more volatile than Denali Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Denali Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  606.00  in Coya Therapeutics, Common on September 5, 2024 and sell it today you would lose (4.00) from holding Coya Therapeutics, Common or give up 0.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Coya Therapeutics, Common  vs.  Denali Therapeutics

 Performance 
       Timeline  
Coya Therapeutics, Common 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Coya Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Denali Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong essential indicators, Denali Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Coya Therapeutics, and Denali Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coya Therapeutics, and Denali Therapeutics

The main advantage of trading using opposite Coya Therapeutics, and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.
The idea behind Coya Therapeutics, Common and Denali Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments